These phenomena indicate that the mRNA expression level of TMPRSS2 could impact the clinicopathological parameters of lung cancer but the differences in prognosis patterns between LUAD and LUSC are less affected by the TMPRSS2-depended clinicopathological parameters. Here, TMPRSS2 is linked to lung carcinoma.